MetaADEDB 2.0 @ LMMD
Insulin Glargine
(COCFEDIXXNGUNL-RFKWWTKHSA-N)
Structure
SMILES
NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCNC(=N)N)CCCNC(=N)N)[C@H](O)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@H](CC)C)NC(=O)CN)CCC(=O)O)CCC(=O)N)C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CC(C)C)Cc1ccc(cc1)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)Cc1nc[nH]c1)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccccc1)N)CC(=O)N)CCC(=O)N)Cc1nc[nH]c1)CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)[C@H](CC)C)CO)[C@H](O)C)C(=O)NCC(=O)O)CCC(=O)O)CCCNC(=N)N)Cc1ccccc1)Cc1ccc(cc1)O
Molecular Formula:
C267H404N72O78S6
Molecular Weight:
6062.890
Log P:
5.9233
Hydrogen Bond Acceptor:
154
Hydrogen Bond Donor:
85
TPSA:
2589.78
CAS Number(s):
160337-95-1
Synonym(s)
1.
Insulin Glargine
2.
A21-Gly-B31-Arg-B32-Arg-insulin
3.
Basaglar
4.
Glargine
5.
HOE 901
6.
HOE-901
7.
Insulin, Gly(A21)-Arg(B31,B32)
8.
Insulin, Glycyl(A21)-Arginyl(B31,B32)
9.
Lantus
10.
Lantus Solostar
11.
901, HOE
12.
A21 Gly B31 Arg B32 Arg insulin
13.
Glargine, Insulin
14.
HOE901
15.
Solostar, Lantus
External Link(s)
MeSHD000069036
PubChem Compound118984454
44146714
Therapeutic Target DatabaseD07NGZ
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood glucose increasedFAERS: 2889
Canada Vigilance: 88
Canada Vigilance
US FAERS
2Device operational issueFAERS: 913US FAERS
3Inappropriate schedule of product administrationFAERS: 892
Canada Vigilance: 2
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 734
Canada Vigilance: 129
Canada Vigilance
US FAERS
5Product dose omissionFAERS: 693
Canada Vigilance: 3
Canada Vigilance
US FAERS
6Blood glucose decreasedFAERS: 667
Canada Vigilance: 4
Canada Vigilance
US FAERS
7Visual ImpairmentFAERS: 621
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
8Drug dose omissionFAERS: 602US FAERS
9Injection site painFAERS: 561
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
10Product use issueFAERS: 513
Canada Vigilance: 4
Canada Vigilance
US FAERS
11Cerebrovascular accidentFAERS: 486
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
12MalaiseFAERS: 452
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Product storage errorFAERS: 417
Canada Vigilance: 3
Canada Vigilance
US FAERS
14Blood glucose abnormalFAERS: 396
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
15Incorrect dose administeredFAERS: 365US FAERS
16Myocardial InfarctionFAERS: 314
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
17DizzinessFAERS: 284
Canada Vigilance: 4
Canada Vigilance
US FAERS
18Blood glucose fluctuationFAERS: 237
Canada Vigilance: 1
Canada Vigilance
US FAERS
19Drug administration errorFAERS: 221US FAERS
20Feeling abnormalFAERS: 212
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Weight decreasedFAERS: 210
Canada Vigilance: 3
Canada Vigilance
US FAERS
22Product quality issueFAERS: 203
Canada Vigilance: 13
Canada Vigilance
US FAERS
23BlindnessFAERS: 198SIDER
US FAERS
24HeadacheFAERS: 197
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
25Diabetes mellitus inadequate controlFAERS: 193
Canada Vigilance: 14
Canada Vigilance
US FAERS
26Accidental underdoseFAERS: 184US FAERS
27PainFAERS: 178
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
28AstheniaFAERS: 176
Canada Vigilance: 3
Canada Vigilance
US FAERS
29Incorrect dose administered by deviceFAERS: 168
Canada Vigilance: 1
Canada Vigilance
US FAERS
30FatigueFAERS: 167
Canada Vigilance: 4
Canada Vigilance
US FAERS
31NauseaFAERS: 167US FAERS
32CataractFAERS: 164SIDER
US FAERS
33PneumoniaFAERS: 160US FAERS
34Memory impairmentFAERS: 156US FAERS
35TremorFAERS: 153
Canada Vigilance: 2
Canada Vigilance
US FAERS
36PruritusFAERS: 146
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
37DisabilityFAERS: 143US FAERS
38Injection site bruisingFAERS: 139US FAERS
39Device malfunctionFAERS: 138US FAERS
40VomitingFAERS: 137
Canada Vigilance: 2
Canada Vigilance
US FAERS
41Diabetic KetoacidosisFAERS: 124
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Unevaluable eventFAERS: 124
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Drug exposure during pregnancyFAERS: 118US FAERS
44Injury associated with deviceFAERS: 116US FAERS
45Wrong technique in product usage processFAERS: 110US FAERS
46Inappropriate schedule of drug administrationFAERS: 108US FAERS
47Peripheral swellingFAERS: 107
Canada Vigilance: 5
Canada Vigilance
US FAERS
48HypersensitivityFAERS: 106
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
49NasopharyngitisFAERS: 99US FAERS
50Intentional product misuseFAERS: 95
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Burning sensationFAERS: 88US FAERS
52ArthralgiaFAERS: 80
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
53ArthritisFAERS: 80US FAERS
54Back PainFAERS: 79
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
55SomnolenceFAERS: 78US FAERS
56Chest PainFAERS: 77
Canada Vigilance: 2
Canada Vigilance
US FAERS
57Pharmaceutical product complaintFAERS: 74US FAERS
58Device leakageFAERS: 73US FAERS
59Intentional product use issueFAERS: 73
Canada Vigilance: 2
Canada Vigilance
US FAERS
60Urinary tract infectionFAERS: 72SIDER
US FAERS
61UrticariaFAERS: 70
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
62AnxietyFAERS: 68US FAERS
63Medication ErrorFAERS: 68
Canada Vigilance: 2
Canada Vigilance
US FAERS
64NervousnessFAERS: 68
Canada Vigilance: 1
Canada Vigilance
US FAERS
65DementiaFAERS: 65US FAERS
66Device defectiveFAERS: 65US FAERS
67GlaucomaFAERS: 63US FAERS
68InfectionFAERS: 63SIDER
US FAERS
69KetoacidosisFAERS: 63
Canada Vigilance: 2
Canada Vigilance
US FAERS
70Needle issueFAERS: 63US FAERS
71PalpitationsFAERS: 62
Canada Vigilance: 3
Canada Vigilance
US FAERS
72Cardiac ArrestFAERS: 61
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Device breakageFAERS: 61US FAERS
74Abdominal discomfortFAERS: 60US FAERS
75Adverse eventFAERS: 60US FAERS
76Expired product administeredFAERS: 57
Canada Vigilance: 3
Canada Vigilance
US FAERS
77ThrombosisFAERS: 56US FAERS
78Diabetic RetinopathyFAERS: 55SIDER
US FAERS
79Inability to afford medicationFAERS: 55US FAERS
80Incorrect product storageFAERS: 54US FAERS
81SwellingFAERS: 54SIDER
US FAERS
82DehydrationFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Injection site massFAERS: 52SIDER
US FAERS
84Pancreatic carcinomaFAERS: 52US FAERS
85Atrial FibrillationFAERS: 51US FAERS
86Product use complaintFAERS: 49US FAERS
87Diabetes MellitusFAERS: 48
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
88Limb injuryFAERS: 48US FAERS
89PancreatitisFAERS: 48US FAERS
90InfluenzaFAERS: 47SIDER
US FAERS
91Macular degenerationFAERS: 47US FAERS
92OverdoseFAERS: 47US FAERS
93SyncopeFAERS: 46US FAERS
94AmnesiaFAERS: 44US FAERS
95DeafnessFAERS: 44US FAERS
96Injection Site ReactionFAERS: 44SIDER
US FAERS
97StressFAERS: 44US FAERS
98Abdominal PainFAERS: 42SIDER
US FAERS
99Device use issueFAERS: 42US FAERS
100HypotensionFAERS: 42
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
101MyalgiaFAERS: 42
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
102Extra dose administeredFAERS: 41US FAERS
103Suicide attemptFAERS: 40US FAERS
104Wrong technique in device usage processFAERS: 38US FAERS
105AsthmaFAERS: 37SIDER
US FAERS
106Back disorderFAERS: 37US FAERS
107Limb discomfortFAERS: 37US FAERS
108ArthropathyFAERS: 36US FAERS
109ErythemaFAERS: 36SIDER
US FAERS
110SepsisFAERS: 36US FAERS
111DysgeusiaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
112Acute myocardial infarctionFAERS: 32US FAERS
113Diabetic FootFAERS: 32US FAERS
114GangreneFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
115Skin UlcerFAERS: 32US FAERS
116Gait inabilityFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
117General physical health deteriorationFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
118AlopeciaFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
119Cataract operationFAERS: 29US FAERS
120CellulitisFAERS: 29US FAERS
121Injection site erythemaFAERS: 29US FAERS
122Musculoskeletal PainFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
123Product contamination with body fluidFAERS: 28US FAERS
124ConstipationFAERS: 27US FAERS
125DysphoniaFAERS: 27US FAERS
126Hepatitis CFAERS: 27US FAERS
127NephrolithiasisFAERS: 27US FAERS
128Product packaging quantity issueFAERS: 27US FAERS
129BronchitisFAERS: 26SIDER
US FAERS
130Coronary Artery DiseaseFAERS: 26US FAERS
131Device FailureFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
132Multiple use of single-use productFAERS: 26US FAERS
133Ankle FractureFAERS: 25US FAERS
134AbasiaFAERS: 24US FAERS
135Chest discomfortFAERS: 24US FAERS
136HungerFAERS: 24US FAERS
137Maternal exposure during pregnancyFAERS: 24US FAERS
138Product administration errorFAERS: 24
Canada Vigilance: 6
Canada Vigilance
US FAERS
139Rheumatoid ArthritisFAERS: 24US FAERS
140BedriddenFAERS: 23US FAERS
141DyspepsiaFAERS: 23US FAERS
142Accidental overdoseFAERS: 22US FAERS
143ChillsFAERS: 22US FAERS
144Injection site pruritusFAERS: 22US FAERS
145ThirstFAERS: 22US FAERS
146Accidental exposure to productFAERS: 21US FAERS
147Angina PectorisFAERS: 21US FAERS
148FractureFAERS: 21SIDER
US FAERS
149Impaired work abilityFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
150Joint swellingFAERS: 21US FAERS
151Neck PainFAERS: 21US FAERS
152VertigoFAERS: 21US FAERS
153Injection site injuryFAERS: 20US FAERS
154Intentional dose omissionFAERS: 20US FAERS
155OsteomyelitisFAERS: 20US FAERS
156Wheelchair userFAERS: 20US FAERS
157Blood cholesterol increasedFAERS: 19US FAERS
158Joint injuryFAERS: 19US FAERS
159DiscomfortFAERS: 18US FAERS
160DisorientationFAERS: 18US FAERS
161Night sweatsFAERS: 18US FAERS
162AphasiaFAERS: 17US FAERS
163Drug prescribing errorFAERS: 17US FAERS
164DysarthriaFAERS: 17US FAERS
165Pulmonary EmbolismFAERS: 17US FAERS
166Rotator cuff syndromeFAERS: 17US FAERS
167Blood creatinine increasedFAERS: 16US FAERS
168Retinal DetachmentFAERS: 16US FAERS
169Wrong technique in drug usage processFAERS: 16US FAERS
170Apparent deathFAERS: 15US FAERS
171Carpal Tunnel SyndromeFAERS: 15US FAERS
172Cerebral InfarctionFAERS: 15US FAERS
173Cold sweatFAERS: 15US FAERS
174CystitisFAERS: 15US FAERS
175Device ineffectiveFAERS: 15US FAERS
176FlatulenceFAERS: 15US FAERS
177Incorrect route of drug administrationFAERS: 15US FAERS
178No adverse eventFAERS: 15US FAERS
179Product packaging issueFAERS: 15US FAERS
180Respiratory arrestFAERS: 15US FAERS
181SinusitisFAERS: 15SIDER
US FAERS
182AgitationFAERS: 14US FAERS
183AngioedemaFAERS: 14SIDER
US FAERS
184Device difficult to useFAERS: 14US FAERS
185Diabetic metabolic decompensationFAERS: 14US FAERS
186DysuriaFAERS: 14US FAERS
187InfarctionFAERS: 14US FAERS
188InflammationFAERS: 14SIDER
US FAERS
189Insulin ResistanceFAERS: 14US FAERS
190LethargyFAERS: 14US FAERS
191Oropharyngeal painFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
192Product dispensing errorFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
193nervous system disorderFAERS: 14SIDER
US FAERS
194AmputationFAERS: 13US FAERS
195CholelithiasisFAERS: 13US FAERS
196Expired drug administeredFAERS: 13US FAERS
197Feeling jitteryFAERS: 13US FAERS
198FlushingFAERS: 13US FAERS
199HypersomniaFAERS: 13US FAERS
200Injection site urticariaFAERS: 13US FAERS
201Limb operationFAERS: 13US FAERS
202Lip swellingFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
203Mental impairmentFAERS: 13US FAERS
204SneezingFAERS: 13US FAERS
205TachycardiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
206Wrong drug administeredFAERS: 13US FAERS
207Blood ketone bodyFAERS: 12US FAERS
208Cerebral ThrombosisFAERS: 12US FAERS
209GoutFAERS: 12US FAERS
210Hearing disabilityFAERS: 12US FAERS
211HemiplegiaFAERS: 12US FAERS
212Injection site extravasationFAERS: 12US FAERS
213LymphomaFAERS: 12US FAERS
214Altered state of consciousnessFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
215CryingFAERS: 11US FAERS
216Depressed moodFAERS: 11US FAERS
217Device dispensing errorFAERS: 11US FAERS
218Eye painFAERS: 11US FAERS
219Gastrointestinal carcinomaFAERS: 11US FAERS
220HerniaFAERS: 11US FAERS
221Incorrect drug administration durationFAERS: 11US FAERS
222Incorrect product administration durationFAERS: 11US FAERS
223Injection site hypersensitivityFAERS: 11US FAERS
224Injection site noduleFAERS: 11US FAERS
225Injection site scarFAERS: 11US FAERS
226Multiple SclerosisFAERS: 11US FAERS
227Nerve injuryFAERS: 11US FAERS
228NoduleFAERS: 11US FAERS
229Poor quality drug administeredFAERS: 11US FAERS
230Product label confusionFAERS: 11US FAERS
231Pulmonary FibrosisFAERS: 11US FAERS
232Skin lesionFAERS: 11US FAERS
233Throat irritationFAERS: 11US FAERS
234Wrong scheduleFAERS: 11US FAERS
235Completed SuicideFAERS: 10US FAERS
236Device occlusionFAERS: 10US FAERS
237Disease ProgressionFAERS: 10US FAERS
238Dry skinFAERS: 10US FAERS
239Feeling ColdFAERS: 10US FAERS
240HepatitisFAERS: 10US FAERS
241Lower respiratory tract infectionFAERS: 10US FAERS
242Musculoskeletal stiffnessFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
243NeuralgiaFAERS: 10US FAERS
244Product substitution issueFAERS: 10US FAERS
245RestlessnessFAERS: 10US FAERS
246Thermal burnFAERS: 10US FAERS
247TuberculosisFAERS: 10US FAERS
248WheezingFAERS: 10US FAERS
249jaundiceFAERS: 10US FAERS
250Acute kidney injuryFAERS: 9US FAERS
251AngerFAERS: 9US FAERS
252Atrioventricular BlockFAERS: 9US FAERS
253Circumstance or information capable of leading to medication errorFAERS: 9US FAERS
254Drug dispensing errorFAERS: 9US FAERS
255DysgraphiaFAERS: 9US FAERS
256EpilepsyFAERS: 9US FAERS
257HypophagiaFAERS: 9US FAERS
258Injection site discomfortFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
259Malignant neoplasm progressionFAERS: 9US FAERS
260ObesityFAERS: 9US FAERS
261Product contamination physicalFAERS: 9US FAERS
262Respiratory FailureFAERS: 9US FAERS
263Respiratory distressFAERS: 9US FAERS
264SpondylitisFAERS: 9US FAERS
265Sudden deathFAERS: 9US FAERS
266TinnitusFAERS: 9US FAERS
267Unresponsive to stimuliFAERS: 9US FAERS
268Activities of daily living impairedFAERS: 8US FAERS
269AngioplastyFAERS: 8US FAERS
270Blood ketone body increasedFAERS: 8US FAERS
271Cerebral disorderFAERS: 8US FAERS
272Clostridium difficile infectionFAERS: 8US FAERS
273DiplopiaFAERS: 8US FAERS
274EpistaxisFAERS: 8US FAERS
275Eye InfectionFAERS: 8US FAERS
276FibromyalgiaFAERS: 8US FAERS
277Foreign body traumaFAERS: 8US FAERS
278Impaired gastric emptyingFAERS: 8US FAERS
279Injection site irritationFAERS: 8US FAERS
280Irritable Bowel SyndromeFAERS: 8US FAERS
281Medical device complicationFAERS: 8US FAERS
282Musculoskeletal discomfortFAERS: 8SIDER
US FAERS
283PallorFAERS: 8US FAERS
284Post procedural complicationFAERS: 8US FAERS
285PregnancyFAERS: 8US FAERS
286Product container issueFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
287Therapy cessationFAERS: 8US FAERS
288UlcerFAERS: 8US FAERS
289Uterine CancerFAERS: 8US FAERS
290Wound InfectionFAERS: 8US FAERS
291Wrong doseFAERS: 8US FAERS
292Wrong patient received productFAERS: 8US FAERS
293treatment failureFAERS: 8US FAERS
294AbscessFAERS: 7US FAERS
295AnorexiaFAERS: 7US FAERS
296AphoniaFAERS: 7US FAERS
297AscitesFAERS: 7US FAERS
298AsphyxiaFAERS: 7US FAERS
299Bipolar DisorderFAERS: 7US FAERS
300Blood potassium increasedFAERS: 7US FAERS
301Bone painFAERS: 7US FAERS
302Corrective lens userFAERS: 7US FAERS
303CystFAERS: 7US FAERS
304Deep Vein ThrombosisFAERS: 7US FAERS
305Drug effect incompleteFAERS: 7US FAERS
306EructationFAERS: 7US FAERS
307GastroenteritisFAERS: 7SIDER
US FAERS
308Head discomfortFAERS: 7US FAERS
309Incorrect dose administered by productFAERS: 7US FAERS
310Injection site vesiclesFAERS: 7US FAERS
311Intervertebral disc disorderFAERS: 7US FAERS
312Liquid product physical issueFAERS: 7US FAERS
313Mental status changesFAERS: 7US FAERS
314OsteoporosisFAERS: 7US FAERS
315Poor peripheral circulationFAERS: 7US FAERS
316Product leakageFAERS: 7US FAERS
317Productive CoughFAERS: 7US FAERS
318PsoriasisFAERS: 7US FAERS
319Restless Legs SyndromeFAERS: 7US FAERS
320Septic ShockFAERS: 7US FAERS
321Therapeutic response unexpectedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
322Therapy changeFAERS: 7US FAERS
323Throat cancerFAERS: 7US FAERS
324Vitreous floatersFAERS: 7US FAERS
325AcneFAERS: 6US FAERS
326Application site painFAERS: 6SIDER
US FAERS
327Blood iron decreasedFAERS: 6US FAERS
328Blood potassium decreasedFAERS: 6US FAERS
329Blood sodium decreasedFAERS: 6US FAERS
330Blood urine presentFAERS: 6US FAERS
331Breast cancer recurrentFAERS: 6US FAERS
332ChokingFAERS: 6US FAERS
333ColitisFAERS: 6US FAERS
334Depressed Level of ConsciousnessFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
335Device damageFAERS: 6US FAERS
336Diabetic NephropathyFAERS: 6US FAERS
337Disease complicationFAERS: 6US FAERS
338DiverticulitisFAERS: 6US FAERS
339Drug abuseFAERS: 6US FAERS
340Drug administered in wrong deviceFAERS: 6US FAERS
341Drug dose omission by deviceFAERS: 6US FAERS
342Gastric ulcerFAERS: 6US FAERS
343HypothyroidismFAERS: 6US FAERS
344Incorrect route of product administrationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
345Joint stiffnessFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
346LaryngitisFAERS: 6US FAERS
347Medical device discomfortFAERS: 6US FAERS
348Metastatic NeoplasmFAERS: 6US FAERS
349MonoplegiaFAERS: 6US FAERS
350Pericardial effusionFAERS: 6US FAERS
351PeritonitisFAERS: 6US FAERS
352PolydipsiaFAERS: 6US FAERS
353PresyncopeFAERS: 6US FAERS
354Product administered at inappropriate siteFAERS: 6US FAERS
355Product contaminationFAERS: 6US FAERS
356Product label issueFAERS: 6US FAERS
357Pulmonary congestionFAERS: 6US FAERS
358Renal cancer metastaticFAERS: 6US FAERS
359RetchingFAERS: 6US FAERS
360Skin reactionFAERS: 6US FAERS
361Soft Tissue InfectionFAERS: 6US FAERS
362StillbirthFAERS: 6US FAERS
363Urine ketone body presentFAERS: 6US FAERS
364Walking aid userFAERS: 6US FAERS
365furuncleFAERS: 6US FAERS
366Acute Coronary SyndromeFAERS: 5SIDER
US FAERS
367Alanine Aminotransferase IncreasedFAERS: 5US FAERS
368Anti-insulin antibody positiveFAERS: 5US FAERS
369ArteriosclerosisFAERS: 5US FAERS
370Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
371Blood triglycerides increasedFAERS: 5US FAERS
372BradycardiaFAERS: 5US FAERS
373ChromaturiaFAERS: 5US FAERS
374Disease recurrenceFAERS: 5US FAERS
375Dose calculation errorFAERS: 5US FAERS
376Facial paralysisFAERS: 5US FAERS
377GastritisFAERS: 5US FAERS
378Gastrointestinal infectionFAERS: 5US FAERS
379HyperphagiaFAERS: 5US FAERS
380HypokinesiaFAERS: 5US FAERS
381IncoherentFAERS: 5US FAERS
382Injection site atrophyFAERS: 5US FAERS
383Injection site warmthFAERS: 5US FAERS
384Intestinal ObstructionFAERS: 5US FAERS
385Loss of personal independence in daily activitiesFAERS: 5US FAERS
386Mood swingsFAERS: 5US FAERS
387Ocular discomfortFAERS: 5US FAERS
388PolyuriaFAERS: 5US FAERS
389Poor quality sleepFAERS: 5US FAERS
390Post procedural infectionFAERS: 5US FAERS
391Product physical issueFAERS: 5US FAERS
392Rash erythematousFAERS: 5US FAERS
393SciaticaFAERS: 5US FAERS
394Skin irritationFAERS: 5US FAERS
395Spinal column injuryFAERS: 5US FAERS
396Vascular occlusionFAERS: 5US FAERS
397Viral upper respiratory tract infectionFAERS: 5US FAERS
398Visual disturbanceFAERS: 5US FAERS
399intensive careFAERS: 5US FAERS
400AcidosisFAERS: 4US FAERS
401AstigmatismFAERS: 4US FAERS
402Blood pressure inadequately controlledFAERS: 4US FAERS
403Carotid artery occlusionFAERS: 4US FAERS
404Cartilage injuryFAERS: 4US FAERS
405Catheter placementFAERS: 4US FAERS
406ChemotherapyFAERS: 4US FAERS
407CholecystitisFAERS: 4US FAERS
408DeliriumFAERS: 4US FAERS
409DermatitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
410Diabetic foot infectionFAERS: 4US FAERS
411Diabetic mastopathyFAERS: 4US FAERS
412Emotional disorderFAERS: 4US FAERS
413Expired device usedFAERS: 4US FAERS
414Frustration tolerance decreasedFAERS: 4US FAERS
415Gastric BypassFAERS: 4US FAERS
416HydronephrosisFAERS: 4US FAERS
417HysterectomyFAERS: 4US FAERS
418IncontinenceFAERS: 4US FAERS
419Incorrect storage of drugFAERS: 4US FAERS
420Insurance issueFAERS: 4US FAERS
421Intestinal PerforationFAERS: 4US FAERS
422Intestinal resectionFAERS: 4US FAERS
423KetosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
424LacerationFAERS: 4US FAERS
425Ligament ruptureFAERS: 4US FAERS
426Lip and/or oral cavity cancerFAERS: 4US FAERS
427Myasthenia GravisFAERS: 4US FAERS
428MyopiaFAERS: 4US FAERS
429Oral painFAERS: 4US FAERS
430Pancreatic CystFAERS: 4US FAERS
431PhotophobiaFAERS: 4US FAERS
432PneumothoraxFAERS: 4US FAERS
433PolyhydramniosFAERS: 4US FAERS
434Product formulation issueFAERS: 4US FAERS
435Pulmonary HypertensionFAERS: 4US FAERS
436Renal Cell CarcinomaFAERS: 4US FAERS
437RhinitisFAERS: 4SIDER
US FAERS
438ScreamingFAERS: 4US FAERS
439ShockFAERS: 4SIDER
US FAERS
440Spinal column stenosisFAERS: 4US FAERS
441Subcutaneous AbscessFAERS: 4US FAERS
442Tooth LossFAERS: 4US FAERS
443VIIth nerve paralysisFAERS: 4US FAERS
444Venous occlusionFAERS: 4US FAERS
445Wrong patient received medicationFAERS: 4US FAERS
446Wrong product administeredFAERS: 4US FAERS
447AgeusiaFAERS: 3US FAERS
448AgraphiaFAERS: 3US FAERS
449Animal scratchFAERS: 3US FAERS
450AphagiaFAERS: 3US FAERS
451AppendicitisFAERS: 3US FAERS
452AtherosclerosisFAERS: 3US FAERS
453Atrial FlutterFAERS: 3US FAERS
454Blood blisterFAERS: 3US FAERS
455Blood cholesterol abnormalFAERS: 3US FAERS
456Blood count abnormalFAERS: 3US FAERS
457Blood potassium abnormalFAERS: 3US FAERS
458Blood pressure fluctuationFAERS: 3US FAERS
459Bowel movement irregularityFAERS: 3US FAERS
460ColectomyFAERS: 3US FAERS
461Complication associated with deviceFAERS: 3US FAERS
462Complications of maternal exposure to therapeutic drugsFAERS: 3US FAERS
463Corneal ScarFAERS: 3US FAERS
464CyanosisFAERS: 3US FAERS
465Dawn phenomenonFAERS: 3US FAERS
466Dengue FeverFAERS: 3US FAERS
467Device infusion issueFAERS: 3US FAERS
468Diabetic ulcerFAERS: 3US FAERS
469Drug DependenceFAERS: 3US FAERS
470Drug administered to patient of inappropriate ageFAERS: 3US FAERS
471Ear congestionFAERS: 3US FAERS
472EmbolismFAERS: 3US FAERS
473EnteritisFAERS: 3US FAERS
474ErysipelasFAERS: 3US FAERS
475Escherichia infectionFAERS: 3US FAERS
476Exposure via skin contactFAERS: 3US FAERS
477Feeding tube userFAERS: 3US FAERS
478FormicationFAERS: 3US FAERS
479Gastrointestinal motility disorderFAERS: 3US FAERS
480Gestational DiabetesFAERS: 3US FAERS
481Grip strength decreasedFAERS: 3US FAERS
482HemiparesisFAERS: 3US FAERS
483Hepatic EncephalopathyFAERS: 3US FAERS
484HepatomegalyFAERS: 3US FAERS
485Hip surgeryFAERS: 3US FAERS
486HyperkeratosisFAERS: 3US FAERS
487Hypertensive crisisFAERS: 3US FAERS
488HypoxiaFAERS: 3US FAERS
489Initial insomniaFAERS: 3US FAERS
490Injection site infectionFAERS: 3US FAERS
491Injection site inflammationFAERS: 3US FAERS
492Intentional device misuseFAERS: 3US FAERS
493Intercepted medication errorFAERS: 3US FAERS
494Intracranial AneurysmFAERS: 3US FAERS
495Intracranial massFAERS: 3US FAERS
496Lipodystrophy acquiredFAERS: 3SIDER
US FAERS
497Loose toothFAERS: 3US FAERS
498MalnutritionFAERS: 3SIDER
US FAERS
499Manufacturing issueFAERS: 3US FAERS
500Meniscus injuryFAERS: 3US FAERS
501Mental FatigueFAERS: 3US FAERS
502Middle insomniaFAERS: 3US FAERS
503Mouth swellingFAERS: 3US FAERS
504Muscle strainFAERS: 3US FAERS
505Nasal discomfortFAERS: 3US FAERS
506OverweightFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
507Pancreatic InsufficiencyFAERS: 3US FAERS
508Pancreatic NeoplasmFAERS: 3US FAERS
509PapuleFAERS: 3US FAERS
510ParanoiaFAERS: 3US FAERS
511Personality ChangeFAERS: 3US FAERS
512Physical disabilityFAERS: 3US FAERS
513PneumonitisFAERS: 3US FAERS
514PolyneuropathyFAERS: 3US FAERS
515Post-Traumatic Stress DisorderFAERS: 3US FAERS
516Product complaintFAERS: 3
Canada Vigilance: 22
Canada Vigilance
US FAERS
517Product prescribing issueFAERS: 3US FAERS
518Product tamperingFAERS: 3US FAERS
519Radiation injuryFAERS: 3US FAERS
520Renal painFAERS: 3US FAERS
521Retinal vascular thrombosisFAERS: 3US FAERS
522SarcoidosisFAERS: 3US FAERS
523SchizophreniaFAERS: 3US FAERS
524Sight disabilityFAERS: 3US FAERS
525Sinus headacheFAERS: 3US FAERS
526Sinus painFAERS: 3US FAERS
527Sjogren's SyndromeFAERS: 3US FAERS
528SluggishnessFAERS: 3US FAERS
529SplenomegalyFAERS: 3US FAERS
530Squamous cell carcinomaFAERS: 3US FAERS
531SyndactylyFAERS: 3US FAERS
532Syringe issueFAERS: 3US FAERS
533Temperature intoleranceFAERS: 3US FAERS
534Tension HeadacheFAERS: 3US FAERS
535Throat clearingFAERS: 3US FAERS
536ThrombocytopeniaFAERS: 3US FAERS
537Ventricular arrhythmiaFAERS: 3US FAERS
538VitrectomyFAERS: 3US FAERS
539Abdominal AbscessFAERS: 2US FAERS
540Abdominal InfectionFAERS: 2US FAERS
541Accidental exposureFAERS: 2US FAERS
542Administration site bruiseFAERS: 2US FAERS
543Alcohol abuseFAERS: 2US FAERS
544AllodyniaFAERS: 2US FAERS
545Amyotrophic Lateral SclerosisFAERS: 2US FAERS
546Anaphylactic shockFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
547AnosmiaFAERS: 2US FAERS
548Anti-insulin antibody increasedFAERS: 2US FAERS
549Apgar score abnormalFAERS: 2US FAERS
550Arthropod stingFAERS: 2US FAERS
551AtaxiaFAERS: 2US FAERS
552Benign Prostatic HyperplasiaFAERS: 2US FAERS
553Biliary ColicFAERS: 2US FAERS
554Bipolar II disorderFAERS: 2US FAERS
555Blood creatine phosphokinase increasedFAERS: 2US FAERS
556Blood insulin abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
557Blood insulin decreasedFAERS: 2US FAERS
558Blood ketone body presentFAERS: 2US FAERS
559Blood thyroid stimulating hormone increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
560Blood urea increasedFAERS: 2US FAERS
561Brain DeathFAERS: 2US FAERS
562CachexiaFAERS: 2US FAERS
563CalcinosisFAERS: 2US FAERS
564Cardiac FlutterFAERS: 2US FAERS
565Cardiac assistance device userFAERS: 2US FAERS
566Cardiac dysfunctionFAERS: 2US FAERS
567CardiomegalyFAERS: 2US FAERS
568Cardiovascular insufficiencyFAERS: 2US FAERS
569Cerebral atrophyFAERS: 2US FAERS
570Cleft PalateFAERS: 2US FAERS
571Coma scale abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
572Complications of transplant surgeryFAERS: 2US FAERS
573Compression fractureFAERS: 2US FAERS
574CystoceleFAERS: 2US FAERS
575Dental cariesFAERS: 2US FAERS
576Device related infectionFAERS: 2US FAERS
577Drug administered at inappropriate siteFAERS: 2US FAERS
578Drug dispensed to wrong patientFAERS: 2US FAERS
579Drug effect delayedFAERS: 2US FAERS
580Drug effect variableFAERS: 2US FAERS
581Drug label confusionFAERS: 2US FAERS
582Drug withdrawal syndromeFAERS: 2US FAERS
583DyslexiaFAERS: 2US FAERS
584DysphemiaFAERS: 2US FAERS
585Ear discomfortFAERS: 2US FAERS
586Economic problemFAERS: 2US FAERS
587Ejection Fraction DecreasedFAERS: 2US FAERS
588Electrocardiogram abnormalFAERS: 2US FAERS
589Emotional distressFAERS: 2US FAERS
590Endoscopy gastrointestinal abnormalFAERS: 2US FAERS
591Erythema NodosumFAERS: 2US FAERS
592EscharFAERS: 2US FAERS
593Exposure during breast feedingFAERS: 2US FAERS
594Exposure via inhalationFAERS: 2US FAERS
595Eye inflammationFAERS: 2US FAERS
596Eye irritationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
597Eye laser surgeryFAERS: 2US FAERS
598Food AllergyFAERS: 2US FAERS
599Food cravingFAERS: 2US FAERS
600FrostbiteFAERS: 2US FAERS
601Gastroenteritis norovirusFAERS: 2US FAERS
602Gastrointestinal PainFAERS: 2SIDER
US FAERS
603General physical condition abnormalFAERS: 2US FAERS
604Glaucoma surgeryFAERS: 2US FAERS
605Guillain-Barre SyndromeFAERS: 2US FAERS
606Head lagFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
607Hepatitis AFAERS: 2US FAERS
608Hepatitis BFAERS: 2US FAERS
609HordeolumFAERS: 2US FAERS
610HyperacusisFAERS: 2US FAERS
611HyperchlorhydriaFAERS: 2US FAERS
612Idiopathic Pulmonary FibrosisFAERS: 2US FAERS
613Immature respiratory systemFAERS: 2US FAERS
614ImmobileFAERS: 2US FAERS
615Impaired driving abilityFAERS: 2US FAERS
616Injection site abscessFAERS: 2US FAERS
617Injection site indentationFAERS: 2US FAERS
618Injection site necrosisFAERS: 2US FAERS
619Intentional device use issueFAERS: 2US FAERS
620Intentional drug misuseFAERS: 2US FAERS
621Intercepted drug dispensing errorFAERS: 2US FAERS
622Intercepted product selection errorFAERS: 2US FAERS
623Intercepted product storage errorFAERS: 2US FAERS
624Intermittent ClaudicationFAERS: 2US FAERS
625Intervertebral Disc DegenerationFAERS: 2US FAERS
626Large intestine perforationFAERS: 2US FAERS
627Leukocytoclastic vasculitisFAERS: 2US FAERS
628LipohypertrophyFAERS: 2SIDER
US FAERS
629LipomaFAERS: 2US FAERS
630Low density lipoprotein increasedFAERS: 2US FAERS
631Lyme DiseaseFAERS: 2US FAERS
632Mallory-Weiss SyndromeFAERS: 2US FAERS
633Maternal exposure timing unspecifiedFAERS: 2US FAERS
634MeningiomaFAERS: 2US FAERS
635MeningitisFAERS: 2US FAERS
636Metabolic acidosisFAERS: 2US FAERS
637Metastases to stomachFAERS: 2US FAERS
638MetastasisFAERS: 2US FAERS
639MonoparesisFAERS: 2US FAERS
640Multiple allergiesFAERS: 2US FAERS
641Muscle tightnessFAERS: 2US FAERS
642Musculoskeletal chest painFAERS: 2US FAERS
643MutismFAERS: 2US FAERS
644MydriasisFAERS: 2US FAERS
645Myocardial necrosis marker increasedFAERS: 2US FAERS
646Neonatal disorderFAERS: 2US FAERS
647Obsessive-Compulsive DisorderFAERS: 2US FAERS
648Occupational exposure to productFAERS: 2US FAERS
649Ocular HypertensionFAERS: 2US FAERS
650Ocular icterusFAERS: 2US FAERS
651Ocular vascular disorderFAERS: 2US FAERS
652Oral infectionFAERS: 2US FAERS
653Oropharyngeal discomfortFAERS: 2SIDER
US FAERS
654Pain of skinFAERS: 2US FAERS
655PancreatectomyFAERS: 2US FAERS
656PancreaticoduodenectomyFAERS: 2US FAERS
657Panic DisorderFAERS: 2US FAERS
658Peripheral arterial occlusive diseaseFAERS: 2US FAERS
659Physical product label issueFAERS: 2US FAERS
660PoisoningFAERS: 2US FAERS
661Premature baby deathFAERS: 2US FAERS
662Procedural complicationFAERS: 2US FAERS
663Product administration interruptedFAERS: 2US FAERS
664Product appearance confusionFAERS: 2US FAERS
665Product availability issueFAERS: 2US FAERS
666Product design issueFAERS: 2US FAERS
667Product expiration date issueFAERS: 2US FAERS
668Product lot number issueFAERS: 2US FAERS
669Product measured potency issueFAERS: 2US FAERS
670Product supply issueFAERS: 2US FAERS
671Product taste abnormalFAERS: 2US FAERS
672Product use in unapproved indicationFAERS: 2US FAERS
673ProteinuriaFAERS: 2US FAERS
674PurpuraFAERS: 2US FAERS
675PurulenceFAERS: 2US FAERS
676PyelonephritisFAERS: 2US FAERS
677QuadriparesisFAERS: 2US FAERS
678Renal massFAERS: 2US FAERS
679Respiratory tract congestionFAERS: 2US FAERS
680Retinitis PigmentosaFAERS: 2US FAERS
681ScabFAERS: 2US FAERS
682Senile dementiaFAERS: 2US FAERS
683Sensitive skinFAERS: 2US FAERS
684Skeletal injuryFAERS: 2US FAERS
685Skin IndurationFAERS: 2US FAERS
686Skin WrinklingFAERS: 2US FAERS
687Skin hypertrophyFAERS: 2US FAERS
688Skin indentationFAERS: 2US FAERS
689Skin tightnessFAERS: 2US FAERS
690Sleep disorder due to a general medical conditionFAERS: 2US FAERS
691Slow speechFAERS: 2US FAERS
692SoporFAERS: 2US FAERS
693Spinal fusion surgeryFAERS: 2US FAERS
694StenosisFAERS: 2US FAERS
695Stevens-Johnson SyndromeFAERS: 2US FAERS
696StomatitisFAERS: 2US FAERS
697SunburnFAERS: 2US FAERS
698Supraventricular tachycardiaFAERS: 2US FAERS
699Temporal ArteritisFAERS: 2US FAERS
700Therapeutic product effect decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
701Thirst decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
702Tissue injuryFAERS: 2US FAERS
703TonsillitisFAERS: 2US FAERS
704Tooth InfectionFAERS: 2US FAERS
705Toxicity to various agentsFAERS: 2US FAERS
706Transcription medication errorFAERS: 2US FAERS
707Trisomy 21FAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
708Typhoid FeverFAERS: 2US FAERS
709UnderweightFAERS: 2US FAERS
710Urinary IncontinenceFAERS: 2US FAERS
711Urinary RetentionFAERS: 2US FAERS
712Urinary tract obstructionFAERS: 2US FAERS
713Ventricular hypertrophyFAERS: 2US FAERS
714Vulvovaginal mycotic infectionFAERS: 2US FAERS
715Vulvovaginal pruritusFAERS: 2US FAERS
716Wrong device usedFAERS: 2US FAERS
717colonoscopyFAERS: 2US FAERS
718liposarcomaFAERS: 2US FAERS
719muscle injuryFAERS: 2US FAERS
720skin abrasionFAERS: 2US FAERS
721Abdominal fat apronFAERS: 1US FAERS
722Abdominal massFAERS: 1US FAERS
723Abdominal strangulated herniaFAERS: 1US FAERS
724Abdominal symptomFAERS: 1US FAERS
725Abnormal sleep-related eventFAERS: 1US FAERS
726Acanthosis NigricansFAERS: 1US FAERS
727Accidental deathFAERS: 1US FAERS
728Accidental needle stickFAERS: 1US FAERS
729Acoustic NeuromaFAERS: 1US FAERS
730Acquired Immunodeficiency SyndromeFAERS: 1US FAERS
731AcromegalyFAERS: 1US FAERS
732Acute respiratory failureFAERS: 1US FAERS
733Administration site reactionFAERS: 1US FAERS
734Adnexa uteri painFAERS: 1US FAERS
735Allergic coughFAERS: 1US FAERS
736Allergic sinusitisFAERS: 1US FAERS
737AmblyopiaFAERS: 1US FAERS
738Ammonia abnormalFAERS: 1US FAERS
739Ammonia increasedFAERS: 1US FAERS
740Amniotic fluid volume decreasedFAERS: 1US FAERS
741AmyloidosisFAERS: 1US FAERS
742Anal FissureFAERS: 1US FAERS
743Anal abscessFAERS: 1US FAERS
744AneurysmFAERS: 1US FAERS
745Angiotensin converting enzyme increasedFAERS: 1US FAERS
746Angle Closure GlaucomaFAERS: 1US FAERS
747Ankle deformityFAERS: 1US FAERS
748Anti-GAD antibody positiveFAERS: 1US FAERS
749Antibody test positiveFAERS: 1US FAERS
750Antipsychotic drug level increasedFAERS: 1US FAERS
751AnuriaFAERS: 1US FAERS
752Aortic AneurysmFAERS: 1US FAERS
753Apallic syndromeFAERS: 1US FAERS
754ApathyFAERS: 1US FAERS
755Aphthous StomatitisFAERS: 1US FAERS
756Aplasia Cutis CongenitaFAERS: 1US FAERS
757Apparent life threatening eventFAERS: 1US FAERS
758Application site nerve damageFAERS: 1US FAERS
759Application site reactionFAERS: 1US FAERS
760Arterial bypass operationFAERS: 1US FAERS
761Arterial thrombosisFAERS: 1US FAERS
762Arthropod biteFAERS: 1US FAERS
763ArthroscopyFAERS: 1US FAERS
764Artificial heart device userFAERS: 1US FAERS
765AsthenopiaFAERS: 1US FAERS
766Atrial tachycardiaFAERS: 1US FAERS
767Atypical pneumoniaFAERS: 1US FAERS
768Automatic bladderFAERS: 1US FAERS
769Autonomic nervous system imbalanceFAERS: 1US FAERS
770Autonomic neuropathyFAERS: 1US FAERS
771Bacterial sepsisFAERS: 1US FAERS
772Basal cell carcinomaFAERS: 1US FAERS
773Biliary dilatationFAERS: 1US FAERS
774Bladder NeoplasmFAERS: 1US FAERS
775Bladder cancer recurrentFAERS: 1US FAERS
776Bladder neoplasm surgeryFAERS: 1US FAERS
777Bladder stenosisFAERS: 1US FAERS
778BlepharospasmFAERS: 1US FAERS
779Blighted ovumFAERS: 1US FAERS
780Blood alkaline phosphatase increasedFAERS: 1US FAERS
781Blood cholesterolFAERS: 1US FAERS
782Blood creatinine abnormalFAERS: 1US FAERS
783Blood glucose false positiveFAERS: 1US FAERS
784Blood glucose normalFAERS: 1US FAERS
785Blood ketone body decreasedFAERS: 1US FAERS
786Blood lactate dehydrogenase increasedFAERS: 1US FAERS
787Blood lactic acidFAERS: 1US FAERS
788Blood pH decreasedFAERS: 1US FAERS
789Blood sodium abnormalFAERS: 1US FAERS
790Body height abnormalFAERS: 1US FAERS
791Body temperature fluctuationFAERS: 1US FAERS
792Bone SarcomaFAERS: 1US FAERS
793Bone density decreasedFAERS: 1US FAERS
794Bone erosionFAERS: 1US FAERS
795Bone fissureFAERS: 1US FAERS
796Bone lesionFAERS: 1US FAERS
797Borderline Personality DisorderFAERS: 1US FAERS
798BradykinesiaFAERS: 1US FAERS
799Brain stem syndromeFAERS: 1US FAERS
800Breast adenomaFAERS: 1US FAERS
801Breast cancer stage IIFAERS: 1US FAERS
802BronchiectasisFAERS: 1US FAERS
803BronchospasmFAERS: 1SIDER
US FAERS
804BruxismFAERS: 1US FAERS
805Buccal mucosal rougheningFAERS: 1US FAERS
806Budd-Chiari SyndromeFAERS: 1US FAERS
807BunionFAERS: 1US FAERS
808Carbon dioxide decreasedFAERS: 1US FAERS
809Carbon dioxide increasedFAERS: 1US FAERS
810CarcinomaFAERS: 1US FAERS
811Cardiac discomfortFAERS: 1US FAERS
812Cardiac enzymes increasedFAERS: 1US FAERS
813Cardiac infectionFAERS: 1US FAERS
814Cardiac stress test abnormalFAERS: 1US FAERS
815CataplexyFAERS: 1US FAERS
816CatatoniaFAERS: 1US FAERS
817Cell DeathFAERS: 1US FAERS
818Central Nervous System InfectionFAERS: 1US FAERS
819Central nervous system lesionFAERS: 1US FAERS
820Cerebellar strokeFAERS: 1US FAERS
821Cerebral artery occlusionFAERS: 1US FAERS
822Cerebral hypoperfusionFAERS: 1US FAERS
823Cerebrovascular stenosisFAERS: 1US FAERS
824Cervix carcinoma stage IFAERS: 1US FAERS
825Cervix carcinomaFAERS: 1US FAERS
826Cervix enlargementFAERS: 1US FAERS
827Charles Bonnet SyndromeFAERS: 1US FAERS
828CheilitisFAERS: 1US FAERS
829Choking sensationFAERS: 1US FAERS
830CholangiocarcinomaFAERS: 1US FAERS
831CholelithotomyFAERS: 1US FAERS
832ChoreaFAERS: 1US FAERS
833Chronic Fatigue SyndromeFAERS: 1US FAERS
834Chronic diseaseFAERS: 1US FAERS
835Chronic sinusitisFAERS: 1US FAERS
836Clostridium difficile colitisFAERS: 1US FAERS
837Cluster HeadacheFAERS: 1US FAERS
838Congenital cystic kidney diseaseFAERS: 1US FAERS
839Congenital hydronephrosisFAERS: 1US FAERS
840Congenital pneumoniaFAERS: 1US FAERS
841Congenital scoliosisFAERS: 1US FAERS
842Conjunctival abrasionFAERS: 1US FAERS
843Continuous Positive Airway PressureFAERS: 1US FAERS
844Coronary artery insufficiencyFAERS: 1US FAERS
845Cyst removalFAERS: 1US FAERS
846Cystic FibrosisFAERS: 1US FAERS
847DebridementFAERS: 1US FAERS
848Decreased bronchial secretionFAERS: 1US FAERS
849Depression suicidalFAERS: 1US FAERS
850Dermal absorption impairedFAERS: 1US FAERS
851DermatomyositisFAERS: 1US FAERS
852Device effect decreasedFAERS: 1US FAERS
853Device physical property issueFAERS: 1US FAERS
854Diabetes mellitus managementFAERS: 1US FAERS
855Diabetic blindnessFAERS: 1US FAERS
856Diabetic glaucomaFAERS: 1US FAERS
857Diabetic keratopathyFAERS: 1US FAERS
858Diabetic neuropathic ulcerFAERS: 1US FAERS
859Diabetic woundFAERS: 1US FAERS
860DiplegiaFAERS: 1US FAERS
861Double Outlet Right VentricleFAERS: 1US FAERS
862DrowningFAERS: 1US FAERS
863Drug ToleranceFAERS: 1US FAERS
864Drug abuserFAERS: 1US FAERS
865Drug effect faster than expectedFAERS: 1US FAERS
866Drug exposure before pregnancyFAERS: 1US FAERS
867Drug exposure via breast milkFAERS: 1US FAERS
868Drug level decreasedFAERS: 1US FAERS
869Drug resistanceFAERS: 1US FAERS
870Drug therapy changedFAERS: 1US FAERS
871Drug toxicityFAERS: 1US FAERS
872DyschromatopsiaFAERS: 1US FAERS
873DystoniaFAERS: 1US FAERS
874Ectopic PregnancyFAERS: 1US FAERS
875EczemaFAERS: 1SIDER
US FAERS
876Ejection fraction abnormalFAERS: 1US FAERS
877Elbow deformityFAERS: 1US FAERS
878Electrolyte imbalanceFAERS: 1US FAERS
879EncephalitisFAERS: 1US FAERS
880EndocarditisFAERS: 1US FAERS
881EndometriosisFAERS: 1US FAERS
882EnuresisFAERS: 1US FAERS
883Environmental ExposureFAERS: 1US FAERS
884EpiglottitisFAERS: 1US FAERS
885Erythema InduratumFAERS: 1US FAERS
886Erythema MultiformeFAERS: 1US FAERS
887Essential HypertensionFAERS: 1US FAERS
888Euphoric moodFAERS: 1US FAERS
889Excessive dynamic airway collapseFAERS: 1US FAERS
890ExophthalmosFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
891Exposure to radiationFAERS: 1US FAERS
892Exposure via breast milkFAERS: 1US FAERS
893Eye complication associated with deviceFAERS: 1US FAERS
894Eye ulcerFAERS: 1US FAERS
895Eyelid erosionFAERS: 1US FAERS
896Facial PainFAERS: 1US FAERS
897Facial ParesisFAERS: 1US FAERS
898Fine motor delayFAERS: 1US FAERS
899Fistula repairFAERS: 1US FAERS
900Fixed eruptionFAERS: 1US FAERS
901Flank PainFAERS: 1US FAERS
902Fluid imbalanceFAERS: 1US FAERS
903Fluid overloadFAERS: 1US FAERS
904Food PoisoningFAERS: 1US FAERS
905Fructosamine increasedFAERS: 1US FAERS
906FrustrationFAERS: 1US FAERS
907Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
908Gastric infectionFAERS: 1US FAERS
909Gastric mucosal lesionFAERS: 1US FAERS
910Gastrointestinal ulcerFAERS: 1US FAERS
911Gastrooesophageal cancerFAERS: 1US FAERS
912General physical condition decreasedFAERS: 1US FAERS
913Genital infectionFAERS: 1US FAERS
914Gingival erythemaFAERS: 1US FAERS
915GlomerulonephritisFAERS: 1US FAERS
916Glucose tolerance increasedFAERS: 1US FAERS
917GlycosuriaFAERS: 1SIDER
US FAERS
918Grief reactionFAERS: 1US FAERS
919Groin infectionFAERS: 1US FAERS
920Hallucinations, mixedFAERS: 1US FAERS
921Head titubationFAERS: 1US FAERS
922Heat StrokeFAERS: 1US FAERS
923Hepatic cancer stage IVFAERS: 1US FAERS
924Hepatorenal SyndromeFAERS: 1US FAERS
925Hernia painFAERS: 1US FAERS
926High density lipoprotein increasedFAERS: 1US FAERS
927Histamine abnormalFAERS: 1US FAERS
928Hormone level abnormalFAERS: 1US FAERS
929Hydrocele operationFAERS: 1US FAERS
930HydrocephalusFAERS: 1US FAERS
931HypercapniaFAERS: 1US FAERS
932HyperinsulinismFAERS: 1US FAERS
933HyperpyrexiaFAERS: 1US FAERS
934HyperthyroidismFAERS: 1US FAERS
935HypertrichosisFAERS: 1US FAERS
936HyperventilationFAERS: 1US FAERS
937Hypoaesthesia facialFAERS: 1US FAERS
938HypogeusiaFAERS: 1US FAERS
939HypophysectomyFAERS: 1US FAERS
940Hyporesponsive to stimuliFAERS: 1US FAERS
941HypospadiasFAERS: 1US FAERS
942Hypothalamo-pituitary disorderFAERS: 1US FAERS
943HypoventilationFAERS: 1US FAERS
944Impaired quality of lifeFAERS: 1US FAERS
945Implantable defibrillator insertionFAERS: 1US FAERS
946Incorrect drug administration rateFAERS: 1US FAERS
947Incorrect product formulation administeredFAERS: 1US FAERS
948Increased bronchial secretionFAERS: 1US FAERS
949Increased insulin requirementFAERS: 1US FAERS
950IndurationFAERS: 1US FAERS
951Infected cystFAERS: 1US FAERS
952Infectious MononucleosisFAERS: 1US FAERS
953Infrequent bowel movementsFAERS: 1US FAERS
954Infusion site painFAERS: 1US FAERS
955Injection site fibrosisFAERS: 1US FAERS
956Injection site lacerationFAERS: 1US FAERS
957Injection site scabFAERS: 1US FAERS
958Injection site ulcerFAERS: 1US FAERS
959Instillation site foreign body sensationFAERS: 1US FAERS
960Instillation site painFAERS: 1SIDER
US FAERS
961Insulin C-peptide increasedFAERS: 1US FAERS
962Insulin autoimmune syndromeFAERS: 1US FAERS
963Insulin resistance syndromeFAERS: 1US FAERS
964Intellectual DisabilityFAERS: 1US FAERS
965Intentional misuseFAERS: 1US FAERS
966Intentional self-injuryFAERS: 1US FAERS
967Intercepted product dispensing errorFAERS: 1US FAERS
968Intervertebral disc injuryFAERS: 1US FAERS
969Intraocular pressure testFAERS: 1US FAERS
970Joint sprainFAERS: 1US FAERS
971KetonuriaFAERS: 1US FAERS
972Knuckle padsFAERS: 1US FAERS
973LabyrinthitisFAERS: 1US FAERS
974Lactose IntoleranceFAERS: 1US FAERS
975LaryngospasmFAERS: 1US FAERS
976Laser TherapyFAERS: 1US FAERS
977Left Ventricular HypertrophyFAERS: 1US FAERS
978LeukocytosisFAERS: 1US FAERS
979Lichen PlanusFAERS: 1US FAERS
980Limb crushing injuryFAERS: 1US FAERS
981Limb massFAERS: 1US FAERS
982Limb prosthesis userFAERS: 1US FAERS
983LipoatrophyFAERS: 1SIDER
US FAERS
984Livedo ReticularisFAERS: 1US FAERS
985Local reactionFAERS: 1US FAERS
986Low birth weight babyFAERS: 1US FAERS
987Lung AbscessFAERS: 1US FAERS
988Lung transplant rejectionFAERS: 1US FAERS
989LymphadenitisFAERS: 1US FAERS
990LymphadenopathyFAERS: 1US FAERS
991MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
992Malabsorption from administration siteFAERS: 1US FAERS
993Malabsorption from injection siteFAERS: 1US FAERS
994MalabsorptionFAERS: 1US FAERS
995Malignant Fibrous HistiocytomaFAERS: 1US FAERS
996Malignant dysphagiaFAERS: 1US FAERS
997MastectomyFAERS: 1US FAERS
998Mechanical ventilation complicationFAERS: 1US FAERS
999Metastases to tonsilsFAERS: 1US FAERS
1000MicroalbuminuriaFAERS: 1US FAERS
1001Multiple System AtrophyFAERS: 1US FAERS
1002Multiple drug therapyFAERS: 1US FAERS
1003Multiple sclerosis relapseFAERS: 1US FAERS
1004Muscle FatigueFAERS: 1US FAERS
1005Muscle RigidityFAERS: 1US FAERS
1006Muscle SpasticityFAERS: 1US FAERS
1007Mycotic allergyFAERS: 1US FAERS
1008MyoclonusFAERS: 1US FAERS
1009MyopathyFAERS: 1US FAERS
1010Neck DissectionFAERS: 1US FAERS
1011NecrosisFAERS: 1US FAERS
1012NephrosclerosisFAERS: 1US FAERS
1013Nephrotic SyndromeFAERS: 1US FAERS
1014NeuritisFAERS: 1US FAERS
1015NeuropathyFAERS: 1SIDER
US FAERS
1016Nipple painFAERS: 1US FAERS
1017No adverse effectFAERS: 1US FAERS
1018NocturiaFAERS: 1US FAERS
1019Non-cirrhotic portal hypertensionFAERS: 1US FAERS
1020OliguriaFAERS: 1US FAERS
1021Oncologic complicationFAERS: 1US FAERS
1022OnychalgiaFAERS: 1US FAERS
1023OnychomycosisFAERS: 1US FAERS
1024Open globe injuryFAERS: 1US FAERS
1025Optic AtrophyFAERS: 1US FAERS
1026Optic NeuritisFAERS: 1US FAERS
1027Oral candidiasisFAERS: 1US FAERS
1028Oral mucosal eruptionFAERS: 1US FAERS
1029OrchitisFAERS: 1US FAERS
1030Orthosis userFAERS: 1US FAERS
1031OsteosarcomaFAERS: 1US FAERS
1032Oxygen consumption decreasedFAERS: 1US FAERS
1033Oxygen supplementationFAERS: 1US FAERS
1034Pancreas islet cell transplantFAERS: 1US FAERS
1035Pancreatic duct obstructionFAERS: 1US FAERS
1036Pancreatic enzymes increasedFAERS: 1US FAERS
1037Pancreatic leakFAERS: 1US FAERS
1038Pancreatic operationFAERS: 1US FAERS
1039Paradoxical drug reactionFAERS: 1US FAERS
1040Paranasal sinus discomfortFAERS: 1US FAERS
1041Paranasal sinus hypersecretionFAERS: 1US FAERS
1042ParaplegiaFAERS: 1US FAERS
1043Paratyphoid FeverFAERS: 1US FAERS
1044ParesisFAERS: 1US FAERS
1045Patent ductus arteriosusFAERS: 1US FAERS
1046Patient dissatisfaction with treatmentFAERS: 1US FAERS
1047Pelvic PainFAERS: 1US FAERS
1048Peptic UlcerFAERS: 1US FAERS
1049Peripheral artery occlusionFAERS: 1US FAERS
1050Peripheral artery stenosisFAERS: 1US FAERS
1051Peripheral venous diseaseFAERS: 1US FAERS
1052Peritoneal DialysisFAERS: 1US FAERS
1053Pharyngitis bacterialFAERS: 1US FAERS
1054PhlebitisFAERS: 1US FAERS
1055PlagiocephalyFAERS: 1US FAERS
1056PleurisyFAERS: 1US FAERS
1057PneumoconiosisFAERS: 1US FAERS
1058PolyarthritisFAERS: 1US FAERS
1059PolydactylyFAERS: 1US FAERS
1060Poor quality device usedFAERS: 1US FAERS
1061Portal Vein ThrombosisFAERS: 1US FAERS
1062Post-traumatic neck syndromeFAERS: 1US FAERS
1063Precancerous skin lesionFAERS: 1US FAERS
1064Pregnancy with contraceptive deviceFAERS: 1US FAERS
1065Prescription drug used without a prescriptionFAERS: 1US FAERS
1066Procedural site reactionFAERS: 1US FAERS
1067Product container seal issueFAERS: 1US FAERS
1068Product counterfeitFAERS: 1US FAERS
1069Product depositFAERS: 1US FAERS
1070Product dispensing issueFAERS: 1US FAERS
1071Product distribution issueFAERS: 1US FAERS
1072Product dosage form issueFAERS: 1US FAERS
1073Product name confusionFAERS: 1US FAERS
1074Product outer packaging issueFAERS: 1US FAERS
1075Product package associated injuryFAERS: 1US FAERS
1076Product physical consistency issueFAERS: 1US FAERS
1077Product prescribing errorFAERS: 1US FAERS
1078Product size issueFAERS: 1US FAERS
1079Prostate examination abnormalFAERS: 1US FAERS
1080Protein total abnormalFAERS: 1US FAERS
1081Protein urine presentFAERS: 1US FAERS
1082Pruritus allergicFAERS: 1US FAERS
1083PseudocystFAERS: 1US FAERS
1084PseudolymphomaFAERS: 1US FAERS
1085Psychomotor skills impairedFAERS: 1US FAERS
1086PterygiumFAERS: 1US FAERS
1087Pulmonary arterial hypertensionFAERS: 1US FAERS
1088Pulmonary malformationFAERS: 1US FAERS
1089Pulmonary thrombosisFAERS: 1US FAERS
1090Pyloric StenosisFAERS: 1US FAERS
1091PyuriaFAERS: 1US FAERS
1092QuadriplegiaFAERS: 1US FAERS
1093Quality of life decreasedFAERS: 1US FAERS
1094Rectal ProlapseFAERS: 1US FAERS
1095Rehabilitation therapyFAERS: 1US FAERS
1096Renal Artery StenosisFAERS: 1US FAERS
1097Renal abscessFAERS: 1US FAERS
1098Renal cystFAERS: 1US FAERS
1099Renal tubular acidosisFAERS: 1US FAERS
1100Retinal Artery OcclusionFAERS: 1US FAERS
1101Retinal Vascular DisorderFAERS: 1SIDER
US FAERS
1102Retinal scarFAERS: 1US FAERS
1103Retinal vascular occlusionFAERS: 1US FAERS
1104RetinitisFAERS: 1US FAERS
1105RetirementFAERS: 1US FAERS
1106Rubber sensitivityFAERS: 1US FAERS
1107Salivary gland painFAERS: 1US FAERS
1108SarcomaFAERS: 1US FAERS
1109Schizoaffective DisorderFAERS: 1US FAERS
1110SclerodermaFAERS: 1US FAERS
1111Seizure like phenomenaFAERS: 1US FAERS
1112Serotonin SyndromeFAERS: 1US FAERS
1113Serum SicknessFAERS: 1US FAERS
1114Single functional kidneyFAERS: 1US FAERS
1115Skin PapillomaFAERS: 1US FAERS
1116Skin discomfortFAERS: 1US FAERS
1117Sleep TalkingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1118Small intestinal bacterial overgrowthFAERS: 1US FAERS
1119Small intestine carcinomaFAERS: 1US FAERS
1120Soft tissue inflammationFAERS: 1US FAERS
1121Soft tissue necrosisFAERS: 1US FAERS
1122Somatic symptom disorderFAERS: 1US FAERS
1123Staphylococcus test positiveFAERS: 1US FAERS
1124StarvationFAERS: 1US FAERS
1125Status EpilepticusFAERS: 1US FAERS
1126Stem cell transplantFAERS: 1US FAERS
1127Stent malfunctionFAERS: 1US FAERS
1128Stroke in evolutionFAERS: 1US FAERS
1129Subcutaneous drug absorption impairedFAERS: 1US FAERS
1130SuperinfectionFAERS: 1US FAERS
1131Supravalvular aortic stenosisFAERS: 1US FAERS
1132Surgical failureFAERS: 1US FAERS
1133Suspected counterfeit productFAERS: 1US FAERS
1134Suspected product tamperingFAERS: 1US FAERS
1135Suture insertionFAERS: 1US FAERS
1136Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
1137Tendon discomfortFAERS: 1US FAERS
1138TensionFAERS: 1US FAERS
1139TetanyFAERS: 1US FAERS
1140Therapeutic procedureFAERS: 1US FAERS
1141Therapeutic product contaminationFAERS: 1US FAERS
1142Therapeutic product effect incompleteFAERS: 1US FAERS
1143Therapeutic product ineffectiveFAERS: 1US FAERS
1144Therapeutic response changedFAERS: 1US FAERS
1145Therapeutic response delayedFAERS: 1US FAERS
1146Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
1147Therapy non-responderFAERS: 1US FAERS
1148Therapy regimen changedFAERS: 1US FAERS
1149ThymomaFAERS: 1US FAERS
1150Tongue discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1151Tonic clonic movementsFAERS: 1US FAERS
1152TonsillectomyFAERS: 1US FAERS
1153Tooth ExtractionFAERS: 1US FAERS
1154TracheitisFAERS: 1US FAERS
1155Transaminases increasedFAERS: 1US FAERS
1156Traumatic fractureFAERS: 1US FAERS
1157Traumatic liver injuryFAERS: 1US FAERS
1158Umbilical herniaFAERS: 1US FAERS
1159UnemploymentFAERS: 1US FAERS
1160Upper respiratory tract congestionFAERS: 1US FAERS
1161Upper-airway cough syndromeFAERS: 1US FAERS
1162Urethral caruncleFAERS: 1US FAERS
1163Urinary tract infection fungalFAERS: 1US FAERS
1164Urinary tract inflammationFAERS: 1US FAERS
1165Urine alcohol test positiveFAERS: 1US FAERS
1166Urine flow decreasedFAERS: 1US FAERS
1167Urine ketone bodyFAERS: 1US FAERS
1168Urine output increasedFAERS: 1US FAERS
1169UrobilinuriaFAERS: 1US FAERS
1170Urological examinationFAERS: 1US FAERS
1171Vaginal DischargeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1172Vascular bypass graftFAERS: 1US FAERS
1173Vascular stent insertionFAERS: 1US FAERS
1174VasculitisFAERS: 1US FAERS
1175Vein collapseFAERS: 1US FAERS
1176Venous ThrombosisFAERS: 1US FAERS
1177Ventricular FibrillationFAERS: 1US FAERS
1178Vitamin D DeficiencyFAERS: 1US FAERS
1179Vocal Cord ParalysisFAERS: 1US FAERS
1180Vulvovaginal burning sensationFAERS: 1US FAERS
1181Vulvovaginal painFAERS: 1US FAERS
1182Waist circumference increasedFAERS: 1US FAERS
1183West Nile virus test positiveFAERS: 1US FAERS
1184White blood cell count decreasedFAERS: 1US FAERS
1185Wound ComplicationFAERS: 1US FAERS
1186Wound infection staphylococcalFAERS: 1US FAERS
1187Wound necrosisFAERS: 1US FAERS
1188Wound sepsisFAERS: 1US FAERS
1189Wrong dosage formulationFAERS: 1US FAERS
1190XerophthalmiaFAERS: 1US FAERS
1191abdominal wall woundFAERS: 1US FAERS
1192angiogramFAERS: 1US FAERS
1193cancer surgeryFAERS: 1US FAERS
1194AmaurosisSIDER
1195Benign neoplasm of skinSIDER
1196Blood glucagon increasedCanada Vigilance: 1Canada Vigilance
1197Hypoglycaemic episodeSIDER
1198LipodystrophySIDER
1199MetrorrhagiaCanada Vigilance: 1Canada Vigilance
1200Micronuclei, Chromosome-Defective27884723CTD
1201NeuroglycopeniaSIDER
1202OphthalmoplegiaCanada Vigilance: 1Canada Vigilance
1203Pharyngeal swellingCanada Vigilance: 2Canada Vigilance
1204PharyngitisSIDER
1205RednessSIDER
1206Tinea PedisCanada Vigilance: 1Canada Vigilance
1207Worsening of diabetesSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.